C. O’Neill

The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history.

C. Mulvaney, S. Mason, T. Nikolopoulos, 2009, Health technology assessment.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Jane S. Paulsen, J. Jankovic, T. Brashers-Krug, 2016, JAMA.

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

L. Seeberger, L. Raymond, R. Barker, 2013, JAMA neurology.

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

J. Jankovic, P. Tariot, B. Leavitt, 2022, CNS Drugs.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Jane S. Paulsen, Megan M. Romer, J. Jankovic, 2016, JAMA neurology.

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

R. Reilmann, K. Marder, J. Corey-Bloom, 2019, The Lancet Neurology.

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS

A. Pestronk, J. Florence, M. Beal, 2005, Neurology.